ongstanding Exercise Therapy in Patients with Rheumatoid Arthritis

Phase 3

Recruiting

Conditions: Rheumatism
Rheumatoid Arthritis
10023213

Registration Number: NL-OMON52885

Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Not specified

Target Recruitment: 215

Inclusion Criteria

In order to be eligible to participate in this study, subjects must meet all of
the following criteria:
a. they are diagnosed with RA by a rheumatologist; b. have severe functional
deterioration despite medical treatment and their functional decline can or
could not be stopped or improved by a short, intermittent physical therapy
intervention; c. they need longstanding active physical therapy because of
severe limitations in daily activities caused by RA such as limited walking
distance, problems with making transfers and/or limitations in self-care; d.
their limitations in daily activities are related to pain, stiffness, muscle
function decline, limited cardiopulmonary condition and or limited motor
control (danger of falling), caused by high disease activity despite optimal
medical treatment and/or severe joint damage and/or deformities and/or sever
comorbidity (e.g. pulmonary or cardiovascular disease, depression, morbid
obesity.

Exclusion Criteria

Potential subjects who meet any of the following criteria will be excluded from
participation in this study: Patients who were individually treated by a
physical therapist and/or a multidisciplinary team in the setting of a
rehabilitation center or rheumatology clinic or center in the last 3 months;
patients in need of immediate admission to a hospital, rehabilitation center or
rheumatology clinic or other forms of intensive, multidisciplinary care.
Patients who are unable to give informed consent.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome measure of effectiveness is the individual level of<br /><br>functioning (activities and participation), as measured with the<br /><br>Patient-Specific Complaints instrument (PSC) at 52 weeks. </p><br>

Secondary Outcome Measures